The Journal of Immunology: 143 (3)

August 1, 1989; Volume 143,Issue 3

ARTICLES

You have accessRestricted access
Fine specificity of T cell recognition of the same peptide in association with different I-A molecules.
S J Brett, K B Cease, C S Ouyang and J A Berzofsky

J Immunol August 1, 1989, 143 (3) 771-779;
You have accessRestricted access
Stimulation of PIP2 hydrolysis by aluminum fluoride in resting T cell subsets of normal and autoimmune-prone lpr mice.
K M Coggeshall and A Altman

J Immunol August 1, 1989, 143 (3) 780-786;
You have accessRestricted access
Transferrin receptor synthesis is an early event in B cell activation.
J Futran, J D Kemp, E H Field, A Vora and R F Ashman

J Immunol August 1, 1989, 143 (3) 787-792;
You have accessRestricted access
Clonogenic potential of murine CD4+8+ thymocytes. Direct demonstration using a V beta 6-specific proliferative stimulus in Mlsa mice.
R C Howe and H R MacDonald

J Immunol August 1, 1989, 143 (3) 793-797;
You have accessRestricted access
CD44 contributes to T cell activation.
S Huet, H Groux, B Caillou, H Valentin, A M Prieur and A Bernard

J Immunol August 1, 1989, 143 (3) 798-801;
You have accessRestricted access
Analysis of the interaction of peptide hen egg white lysozyme (34-45) with the I-Ak molecule.
L E Lambert and E R Unanue

J Immunol August 1, 1989, 143 (3) 802-807;
You have accessRestricted access
A functional role for signal transduction via the cytoplasmic domains of MHC class II proteins.
Y St-Pierre, N Nabavi, Z Ghogawala, L H Glimcher and T H Watts

J Immunol August 1, 1989, 143 (3) 808-812;
You have accessRestricted access
Immunomodulatory activity of staphylococcal enterotoxin-B. The induction of an I-J-restricted suppressor factor.
D D Taub, Y S Lin, S C Hu and T J Rogers

J Immunol August 1, 1989, 143 (3) 813-820;
You have accessRestricted access
The immune response and the eye. III. Anterior chamber-associated immune deviation can be adoptively transferred by serum.
T A Ferguson, J D Hayashi and H J Kaplan

J Immunol August 1, 1989, 143 (3) 821-826;
You have accessRestricted access
Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets.
A C Fischer, M K Laulis, L Horwitz, W E Beschorner and A Hess

J Immunol August 1, 1989, 143 (3) 827-832;
You have accessRestricted access
Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription.
G K Kumkumian, R Lafyatis, E F Remmers, J P Case, S J Kim and R L Wilder

J Immunol August 1, 1989, 143 (3) 833-837;
You have accessRestricted access
Selective abrogation of alloreactivity via priming in the presence of aphidicolin, a specific inhibitor of DNA polymerase.
S Morecki, S Slavin and S A Ben-Sasson

J Immunol August 1, 1989, 143 (3) 838-843;
You have accessRestricted access
Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome.
H C Morse 3rd, R A Yetter, C S Via, R R Hardy, A Cerny, K Hayakawa, A W Hugin, M W Miller, K L Holmes and G M Shearer

J Immunol August 1, 1989, 143 (3) 844-850;
You have accessRestricted access
Identification of a widely distributed 90-kDa glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor.
S T Pals, F Hogervorst, G D Keizer, T Thepen, E Horst and C C Figdor

J Immunol August 1, 1989, 143 (3) 851-857;
You have accessRestricted access
CD8+CD4- lymphocyte lines can harbor the AIDS virus in vitro.
H Tsubota, D J Ringler, M Kannagi, N W King, K R Solomon, J J MacKey, D G Walsh and N L Letvin

J Immunol August 1, 1989, 143 (3) 858-863;
You have accessRestricted access
Activation of normal human B cells through their antigen receptor induces membrane expression of IL-1 alpha and secretion of IL-1 beta.
J Y Bonnefoy, M C Denoroy, O Guillot, C L Martens and J Banchereau

J Immunol August 1, 1989, 143 (3) 864-869;
You have accessRestricted access
IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor.
D K Ferris, J Willette-Brown, J R Ortaldo and W L Farrar

J Immunol August 1, 1989, 143 (3) 870-876;
You have accessRestricted access
Inhibition of early murine hemopoietic progenitor cell proliferation after in vivo locoregional administration of transforming growth factor-beta 1.
H Goey, J R Keller, T Back, D L Longo, F W Ruscetti and R H Wiltrout

J Immunol August 1, 1989, 143 (3) 877-880;
You have accessRestricted access
Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig.
L B Justement, J Kreiger and J C Cambier

J Immunol August 1, 1989, 143 (3) 881-889;
You have accessRestricted access
Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
J B Michel and T Quertermous

J Immunol August 1, 1989, 143 (3) 890-895;
You have accessRestricted access
Synergistic interactions of IL-1 and IL-6 in T cell activation. Mitogen but not antigen receptor-induced proliferation of a cloned T helper cell line is enhanced by exogenous IL-6.
H Mizutani, L T May, P B Sehgal and T S Kupper

J Immunol August 1, 1989, 143 (3) 896-901;
You have accessRestricted access
IL-4-responsive human helper T cell clones are resistant to growth inhibition by tumor necrosis factor-alpha.
G P Pawelec, A Rehbein, K Schaudt and F W Busch

J Immunol August 1, 1989, 143 (3) 902-906;
You have accessRestricted access
Production of lymphokine mRNA by CD45R+ and CD45R- helper T cells from human peripheral blood and by human CD4+ T cell clones.
M Salmon, G D Kitas and P A Bacon

J Immunol August 1, 1989, 143 (3) 907-912;
You have accessRestricted access
Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level.
P Santamaria, R C Gehrz, M K Bryan and J J Barbosa

J Immunol August 1, 1989, 143 (3) 913-922;
You have accessRestricted access
Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
J C Carel, B Frazier, T J Ley and V M Holers

J Immunol August 1, 1989, 143 (3) 923-930;
You have accessRestricted access
Bivalent binding of an anti-CD3 antibody to Jurkat cells induces association of the T cell receptor complex with the cytoskeleton.
N Marano, D Holowka and B Baird

J Immunol August 1, 1989, 143 (3) 931-938;
You have accessRestricted access
IL-2, a lectin with specificity for high mannose glycopeptides.
A P Sherblom, N Sathyamoorthy, J M Decker and A V Muchmore

J Immunol August 1, 1989, 143 (3) 939-944;
You have accessRestricted access
Specific molecular interaction between the insulin receptor and a D product of MHC class I.
S Verland, M Simonsen, S Gammeltoft, H Allen, R A Flavell and L Olsson

J Immunol August 1, 1989, 143 (3) 945-951;
You have accessRestricted access
Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
R L Barker, D A Loegering, R M Ten, K J Hamann, L R Pease and G J Gleich

J Immunol August 1, 1989, 143 (3) 952-955;
You have accessRestricted access
Human peripheral lymphocyte growth regulation and response to phorbol esters is linked to synthesis and phosphorylation of the cytosolic protein, prosolin.
H L Cooper, E McDuffie and R Braverman

J Immunol August 1, 1989, 143 (3) 956-963;
You have accessRestricted access
Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.
C Dubois, E Bissonnette and M Rola-Pleszczynski

J Immunol August 1, 1989, 143 (3) 964-970;
You have accessRestricted access
Plasminogen activator and prostaglandin E2 levels in human synovial fibroblasts. Differential stimulation by synovial activator and other cytokines.
T Leizer and J A Hamilton

J Immunol August 1, 1989, 143 (3) 971-978;
You have accessRestricted access
Human eosinophil cytotoxicity-enhancing factor. Purification, physical characteristics, and partial amino acid sequence of an active polypeptide.
D S Silberstein, M H Ali, S L Baker and J R David

J Immunol August 1, 1989, 143 (3) 979-983;
You have accessRestricted access
Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus.
E Cash, A Bandeira, S Chirinian and M Brahic

J Immunol August 1, 1989, 143 (3) 984-988;
You have accessRestricted access
Characteristics of protective immunity in mice induced by drug-attenuated larvae of Schistosoma mansoni. Antigen localization and antibody responses.
A P Mountford, P S Coulson, N Saunders and R A Wilson

J Immunol August 1, 1989, 143 (3) 989-995;
You have accessRestricted access
Dual action of anti-sporozoite antibodies in vitro.
S Nudelman, L Rénia, Y Charoenvit, L Yuan, F Miltgen, R L Beaudoin and D Mazier

J Immunol August 1, 1989, 143 (3) 996-1000;
You have accessRestricted access
Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
A A Pan and D McMahon-Pratt

J Immunol August 1, 1989, 143 (3) 1001-1008;
You have accessRestricted access
T cell receptor delta gene organization and expression in normal and leukemic natural killer cells.
A Biondi, P Allavena, V Rossi, R Bassan, T Barbui, E Champagne, T W Mak, M D Minden, A Rambaldi and A Mantovani

J Immunol August 1, 1989, 143 (3) 1009-1014;
You have accessRestricted access
Somatostatin gene expression in the thymus gland.
P J Fuller and K Verity

J Immunol August 1, 1989, 143 (3) 1015-1017;
You have accessRestricted access
Mutation of 3' splice sites in two different class I genes results in different usage of cryptic splice sites.
M L Hedley, J Forman and P W Tucker

J Immunol August 1, 1989, 143 (3) 1018-1025;
You have accessRestricted access
Expression of mutant H-2d proteins encoded by class I genes which alternatively process the 5' end of their transcripts.
M L Hedley, K Ozato, J Maryanski, P W Tucker and J Forman

J Immunol August 1, 1989, 143 (3) 1026-1031;
You have accessRestricted access
Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
M J Klemsz, L B Justement, E Palmer and J C Cambier

J Immunol August 1, 1989, 143 (3) 1032-1039;
You have accessRestricted access
A novel VHDJH to JH joining that induces H chain production in an Ig-null immature B cell line.
T Komori, H Sugiyama and S Kishimoto

J Immunol August 1, 1989, 143 (3) 1040-1045;
You have accessRestricted access
Role of transcriptional termination in the regulation of mu mRNA expression in B lymphocytes.
E A Weiss, A Michael and D Yuan

J Immunol August 1, 1989, 143 (3) 1046-1052;
You have accessRestricted access
Tumor idiotype vaccines. VI. Synergistic anti-tumor effects with combined "internal image" anti-idiotypes and chemotherapy.
J J Chen, Y Saeki, L F Shi and H Köhler

J Immunol August 1, 1989, 143 (3) 1053-1057;
You have accessRestricted access
Relationship between target cell recognition and temporal fluctuations in intracellular Ca2+ of human NK cells.
B S Edwards, H A Nolla and R R Hoffman

J Immunol August 1, 1989, 143 (3) 1058-1065;
You have accessRestricted access
Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils.
H Y Shau and S H Golub

J Immunol August 1, 1989, 143 (3) 1066-1072;

LETTERS TO THE EDITOR

You have accessRestricted access
Human leukocyte differentiation antigens.
A Bernard and V Horejsi

J Immunol August 1, 1989, 143 (3) 1073;

Main menu

User menu

Search

Table of Contents

ARTICLES

LETTERS TO THE EDITOR

This Issue

Jump to

Navigate

For Authors

General Information

Journal Services